CYB5R1 and colonic neoplasm: We treated DLD-1 and HCT116 colon cancer cell lines with siRNAs specifically directed against CYB5R1 mRNA, which resulted in reduction of CYB5R1 protein levels in both cell lines, when compared to control siRNA treatment (Figure 4A).